Greg Hanson Email & Phone Number

Southeastern Us

* Help residents in long term care ICF/IID facilities with rare epilepsy conditions. * Identify and develop opportunities to help sales representatives succeed.* Work with top regional and state ICF/IDD group home chains. * Interact with National GPO accounts, pharmacy directors, independent pharmacy providers, and consultant pharmacist groups. * Work with state home health systems, DDNA chapters, American Society of Consultant Pharmacists chapters, and other provider associations. * Establish strategic relationships with C & D-level contacts. * Develop external advocacy partners to ensure success for future Jazz product launches.

Greater Tampa Bay Area

Began Regional Trainer role in 1/22.Promoted to Senior Specialty Sales Consultant in 1/23.

Tampa/St. Petersburg, Florida Area

Sold Xyrem - launched Xywav and Sunosi to Sleep Specialists, Pulmonologists, Neurologists, Psychiatrists and other health care providers.Annual ranking summary: 2022: 14/72; 2021: 9/73; 2020: 19/132; 2019: 8/21.Attained national rank of 3/73 for YTD Xywav prescriptions in 2021.Attained 6th most YTD Xywav prescriptions out of 73 territories.Lone SSC out of 193 to acquire all three level prizes in 2021 Q3 sales contest.

Tampa/St. Petersburg, Florida Area

Bio-pharmaceutical company focused on acquiring and marketing CNS products to treat un-met needs. Launched Onzetra to neurologists and primary care physicians. • Annual ranking summary: 2018: 33/100; 2017: 133/217; 2016: 66/220; 2015: 41/71.• Invited to participate on the 2017 Nuedexta SMAC (field advisory) team.• Selected to represent the Southeastern US on the 2016 Onzetra field advisory board.

Naples, Fort Myers, Sarasota, St. Petersburg And Tampa Florida Area

Launched Nuedexta to neurologists, psychiatrists, primary care and LTC providers. • Annual ranking summary: 2014: 10/71; 2013: 21/71; 2012: 15/73; 2011: 44/76.• Exceeded 2012 annual bonus target with one quarter of sales performance.• Grew volume from 127 prescriptions in 2011 to 1,300 in 2012.

Tampa/St. Petersburg, Florida Area

Private pharmaceutical company focused on acquiring amd marketing mature prescription products for the U.S. psychiatry market.Re-launched and sold Equetro and Marplan to psychiatrists and NPs/PAs in Central Florida. • Achieved annual ranking of #2 in 2010.• Created new territory marketing plan and quickly improved prescription trends. • Successfully convinced psychiatrists to prescribe Equetro over generic Carbamazepine and other branded mood stabilizers.

Launched Symbicort and other respiratory products to specialists in the Tampa Bay area. • Annual ranking summary: 2008: 3/43; 2007: 31/43. • Developed and implemented strategic marketing plan to gain market share from a competitor that had a six-year head start.• One of four in the country to receive the 2008 Symbicort Summit Award for driving market share over 30%. • Generated 169% of YTD goal within the first six months of launch in 2007.

Tampa/St. Petersburg, Florida Area

Launched Crestor and Nexium to cardiovascular and GI specialists. Managed key account selling to over-achieve sales goals. Designed and facilitated in-service presentations to train sales representatives, physicians and nursing staff. Leveraged programs and educational materials to create access and increase sales. • Increased calls and sales in targeted accounts by 84%, which earned me the rank of #1 in the nation. • Obtained five consecutive annual performance ratings of excellent. Utilized excellent leadership and communication skills in working with sales and marketing teams to improve sales representative effectiveness.• Created and delivered three regional marketing research programs within 6 months. Partnered with regional leadership, compliance and legal to get programs approved.

Birmingham, Alabama Area

Successfully launched Rhinocort, Rhinocort Aqua, Pulmicort Turbuhaler and Pulmicort Respules to respiratory specialists and primary care physicians. Managed, coached and led nine sales representatives to achieve their developmental objectives and maximize bonus earnings. • Over-achieved district annual sales goals from 1994 through 1999. Effectively allocated coaching visits and resources to team. Worked with best representatives to learn how lower performers could improve.• Successfully managed four respiratory product launches. Designed and coordinated unique and successful customer programs to drive market share with key accounts.

Greater Grand Rapids, Michigan Area

One of 70 in a new sales force that launched Toprol-XL, a cardiovascular medication. Successfully achieved portfolio sales goals across a large rural territory. • Attained #10 regional ranking. Developed specialists and primary care physicians into advocates through effective planning and selling.• Achieved 179% of national market share average. Focused efforts on physicians in top areas to develop a 41% market share in key zip codes. • Reached YTD share of 11% in first year of launch.